Loading...

Cellect Biotechnology Ltd.

APOP•NASDAQ
Healthcare
Biotechnology
$13.17
$0.05(0.38%)

Cellect Biotechnology Ltd. (APOP) Stock Overview

Explore Cellect Biotechnology Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 60.9/100

Key Financials

Market Cap129M
P/E Ratio-0.02
EPS (TTM)$-0.85
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$8.64

APOP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cellect Biotechnology Ltd. (APOP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $8.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.02 and a market capitalization of 129M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

http://www.cellect.co
972 9 974 1444
23 Hata'as Street, Kfar Saba, 44425

Company Facts

12 Employees
IPO DateJul 29, 2016
CountryIL

Frequently Asked Questions

;